We had a great time in Glasgow for ESHG 2023, connecting with many current customers and prospective customers at our booth. The in-depth conversations were engaging and offered beneficial insights for our team and the attendees. Thank you all for visiting our booth for a demo as well as attending our Corporate Satellite talk. Below are a few themes that we noticed throughout our conversations.
Whole Genome Sequencing & Long Read Analysis
Through our conversations, we identified more providers offering sequencing for long reads, and this becoming an increasing need for analysis. As a result, we had an interest on our end and how we can support customers in that field. Recently, we hosted a webcast showcasing our latest VarSeq 2.4.0 update and our support for long-read sequencing. If you are interested in watching and learning more, please watch VarSeq 2.4.0: VSClinical ACMG Workflow from the User Perspective.
Automation
The importance of automation came up through a variety of conversations. Many attendees seeking to streamline workflows or enhance data analysis are exploring ways to focus their pipelines with analysis automation. The efficiency of workflows for scalability is becoming more common for labs and adding more automation capabilities, such as eliminating manual steps. This level of automation can be seen in a recent webcast, VarSeq 2.4.0: Structural Variants and Advanced Automation in VSClinical ACMG.
Thank you to ESHG for organizing a great event. We enjoyed participating and presenting and look forward to next year in Berlin!
Dr. Andreas Scherer is CEO of Golden Helix. The company has been delivering industry leading bioinformatics solutions for the advancement of life science research and translational medicine for over a decade. Its innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from next-generation sequencing. With its solutions, hundreds of the world’s hospitals and testing labs are able to harness the full potential of genomics to identify the cause of disease, develop genomic diagnostics, and advance the quest for personalized medicine. Golden Helix products and services have been cited in thousands of peer-reviewed publications. Golden Helix is also on the Inc 5000 list of the fastest-growing private companies in the US.
He is also Managing Partner of Salto Partners, Inc, a management consulting firm headquartered in Nevada. He has extensive experience successfully managing growth as well as orchestrating complex turnaround situations. His company, Salto Partners, advises on business strategy, financing, sales, and operations. Clients are operating in the high-tech and life sciences space.
Dr. Scherer holds a Ph.D. in computer science from the University of Hagen, Germany, and a Master of Computer Science from the University of Dortmund, Germany. He is author and co- author of over 20 international publications and has written books on project management, the Internet, and artificial intelligence. His latest book, “Be Fast Or Be Gone”, is a prizewinner in the 2012 Eric Hoffer Book Awards competition, and has been named a finalist in the 2012 Next Generation Indie Book Awards!
